Search Results

Sort by

Our Story

Today, we develop breakthrough medicines, vaccines and technology that improve the health and well-being of animals worldwide.

News Releases

Mexico’s SADER Approves MSD Animal Health’s EXZOLT® 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis)

MSD Animal Health, a division of MSD & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the Mexico’s SADER Approval of EXZOLT® 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis)

Featured Stories

Building a Healthy Future: The Critical Importance of the Vet/Farmer Relationship in Colostrum in Calf Management

Poultry is a cornerstone of global food security. It provides affordable, high-quality protein in the form of both meat and eggs, feeding billions of people worldwide.

Featured Stories

Supporting a Sustainable Future

Healthier animals mean a sustainable food supply, protection for humans against diseases passed from animals, and longer, healthier lives for pets.

News Releases

New Research from MSD Animal Health Reveals “Hidden” Parasitic Infections Cost Global Dairy Industry Billions Each Year

MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced a comprehensive scientific review of dairy cattle parasites has revealed that “hidden” infections are costing the global cattle industry billions of dollars every year.

Allflex Livestock Intelligence

Allflex Livestock Intelligence is the global leader in the design, development, manufacture and delivery of animal identification and monitoring devices.

News Releases

FDA Conditionally Approves MSD Animal Health’s EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.

Ruminants

Pioneering medicines, vaccines, technology, and insights-driven solutions that aim to improve the health and well-being of ruminants, enable a sustainable meat and dairy supply, and protect public health.

About Us

Our singular focus is to empower those who care for animals, helping them manage their vital responsibility with confidence.

News Releases

MSD Animal Health Demonstrates its Commitment to Ruminant Health at the 2025 European Buiatrics Congress

Presenting more than 10 new studies and continuing to solve unmet medical needs in the Ruminant space. Join us at EBC 2025 in France.

12 Next